UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years

PubMed

Insights

Extracorporeal membrane oxygenation (ECMO) improved survival and outcomes for infants with respiratory failure. Long-term follow-up at age 4 showed favorable results for ECMO support compared to conventional care.

Area of Science:

  • Neonatal intensive care
  • Pediatric respiratory support
  • Extracorporeal membrane oxygenation

Background:

  • Acute respiratory failure is a critical condition in neonates.
  • Extracorporeal membrane oxygenation (ECMO) offers advanced life support.
  • Limited long-term data exists for neonatal ECMO outcomes.

Purpose of the Study:

  • To evaluate long-term morbidity at age 4 years in survivors of neonatal ECMO.
  • To compare ECMO support with contemporary conventional care in neonates.
  • To assess the safety and efficacy of neonatal ECMO.

Main Methods:

  • Prospective cohort study of infants receiving ECMO.
  • Follow-up assessment at 4 years of age for morbidity.
  • Comparison of ECMO group with a control group receiving conventional care.

Main Results:

  • Neonatal ECMO policy demonstrated improved survival rates.
  • Survivors of ECMO showed favorable long-term outcomes at age 4.
  • ECMO was associated with a positive overall outcome compared to conventional care.

Conclusions:

  • Neonatal ECMO is a safe and effective intervention for acute respiratory failure.
  • The UK Collaborative ECMO Trial provides crucial long-term data.
  • ECMO support is advocated for critically ill neonates requiring intensive care.